The Wire · Case news

What changed. Why it matters.

Court rulings, settlements, and case developments, with links to the source records.

  1. Roblox child abuse

  2. Suboxone lawsuit: who can file and what happens next

  3. Zantac claim: what to ask and what to do

    MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims.

    MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims. Verified from the court order itself.

    Source: gsk.com

  4. Zantac claim: what to ask and what to do

    Sanofi agreed to pay more than $100 million to settle ~4,000 Zantac cancer suits in state courts outside Delaware — the first major resolution in the litigation, averaging more than $25,000 per claim per Bloomberg's reporting (republished by Insurance Journal, Apr 23, 2024; deal announced earlier that month).

    Sanofi agreed to pay more than $100 million to settle ~4,000 Zantac cancer suits in state courts outside Delaware — the first major resolution in the litigation, averaging more than $25,000 per claim per Bloomberg's reporting (republished by Insurance Journal, Apr 23, 2024; deal announced earlier that month). Sanofi denied liability; 70,000+ suits then remained, mostly in Delaware.

    Source: insurancejournal.com

  5. Zantac claim: what to ask and what to do

    GSK announced agreements with 10 plaintiff firms representing ~80,000 claimants (93% of pending US state-court Zantac cases) to pay up to $2.2 billion in aggregate, with full implementation expected by end of H1 2025; GSK admitted no liability.

    GSK announced agreements with 10 plaintiff firms representing ~80,000 claimants (93% of pending US state-court Zantac cases) to pay up to $2.2 billion in aggregate, with full implementation expected by end of H1 2025; GSK admitted no liability. GSK also agreed to pay $70 million to resolve the Valisure qui tam complaint. Verified from GSK's own press statement.

    Source: us.gsk.com

  6. Depo-Provera shots and brain tumor claims

  7. Talc body powder claims: what to check

  8. Coal ash, exposure and possible claims

    EPA Issues Major Penalties in Chemical Facility Enforcement Actions

    EPA enforcement records detected in July 2026 show federal penalties issued against multiple chemical facilities. Denka Performance Elastomer was assessed a penalty of $996,703 under EPA case 06-2025-0910. Separate actions recorded penalties of $1,265,246 against Hasa, Inc. and $541,110 against AMVAC. The applicable laws, filing dates, and facility locations were not specified in the available enforcement data.

    Source: echo.epa.gov

  9. Ozempic and GLP-1 gut injury claims

    FDA Issues Class I Recall for Omnipod 5 Insulin Pods Over Leak Risk

    The FDA posted a Class I recall for specific Omnipod 5 pod models manufactured by Insulet Corporation. According to the recall notice, a manufacturing defect can damage the external soft cannula, causing insulin to leak around the pod rather than being delivered to the user. The FDA noted that failure to deliver insulin properly could lead to serious health consequences.

    Source: api.fda.gov

  10. Coal ash, exposure and possible claims

    EPA Issues ~$997K Penalty Against Denka Performance Elastomer

    EPA enforcement case 06-2025-0910 lists a federal penalty of $996,703 against Denka Performance Elastomer, according to EPA's ECHO database. The record was detected on July 15, 2026. No further case details — including the specific law cited, filing date, or facility location — were available in the signal.

    Source: echo.epa.gov

  11. Truck crash claim: what can I do?

    NHTSA Opens Multiple Truck-Related Safety Investigations in 2026

    Between March and July 2026, NHTSA opened at least five separate investigations into potential truck safety defects. The probes cover issues including front steering knuckle fractures, rear toe link separation, wheel fastener locking mechanisms, carry handle separation, and fuel smell paired with loss of power. No vehicle makes, models, or docket numbers were included in the available signal data.

    Source: nhtsa.gov

  12. PFAS in Water: What to Check